Initiation of maintenance treatment of persistent asthma: salmeterol/fluticasone propionate combination treatment is more effective than inhaled steroid alone

This publication has 10 references indexed in Scilit:

• Early asthma control and maintenance with eformoterol following reduction of inhaled corticosteroid dose
  Thorax, 2002
• Fluticasone propionate/salmeterol Diskus® combination product provides superior asthma control compared with fluticasone propionate and salmeterol alone in patients previously receiving PRN short-acting beta2-agonists alone
  Journal of Allergy and Clinical Immunology, 2002
• Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma
  American Journal of Respiratory and Critical Care Medicine, 2001
• Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA)
  BMJ, 2000
• Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma
  Annals of Allergy, Asthma & Immunology, 1999
• Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma
  Thorax, 1999
• Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
  American Journal of Respiratory and Critical Care Medicine, 1996
• Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
  The Lancet, 1994
• Lung volumes and forced ventilatory flows
  European Respiratory Journal, 1993
• Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and Asthma
  American Review of Respiratory Disease, 1987